Evidence map›Paper›PMID 28874464›Full record

ArticleHypertension (Dallas, Tex. : 1979)2017

MAS1 Receptor Trafficking Involves ERK1/2 Activation Through a β-Arrestin2-Dependent Pathway.

Flavia M Cerniello, Oscar A Carretero, Nadia A Longo Carbajosa, Bruno D Cerrato, Robson A Santos, Hernán E Grecco, Mariela M Gironacci

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Dimerization of ATCurrent hypertension reports · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Flavia M CernielloFrom the Departamento de Química Biológica, IQUIFIB-CONICET, Universidad de Buenos Aires, Argentina (F.M.C., N.L.C., B.D.C., M.M.G.); Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, MI (O.A.C.); Department of Physiology, Federal University of Minas Gerais, Belo Horizonte, Brazil (R.A.S.); and Departamento de Física, Universidad de Buenos Aires and IFIBA-CONICET, Buenos Aires, Argentina (H.E.G.).
Oscar A CarreteroFrom the Departamento de Química Biológica, IQUIFIB-CONICET, Universidad de Buenos Aires, Argentina (F.M.C., N.L.C., B.D.C., M.M.G.); Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, MI (O.A.C.); Department of Physiology, Federal University of Minas Gerais, Belo Horizonte, Brazil (R.A.S.); and Departamento de Física, Universidad de Buenos Aires and IFIBA-CONICET, Buenos Aires, Argentina (H.E.G.).
Nadia A Longo CarbajosaFrom the Departamento de Química Biológica, IQUIFIB-CONICET, Universidad de Buenos Aires, Argentina (F.M.C., N.L.C., B.D.C., M.M.G.); Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, MI (O.A.C.); Department of Physiology, Federal University of Minas Gerais, Belo Horizonte, Brazil (R.A.S.); and Departamento de Física, Universidad de Buenos Aires and IFIBA-CONICET, Buenos Aires, Argentina (H.E.G.).
Bruno D CerratoFrom the Departamento de Química Biológica, IQUIFIB-CONICET, Universidad de Buenos Aires, Argentina (F.M.C., N.L.C., B.D.C., M.M.G.); Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, MI (O.A.C.); Department of Physiology, Federal University of Minas Gerais, Belo Horizonte, Brazil (R.A.S.); and Departamento de Física, Universidad de Buenos Aires and IFIBA-CONICET, Buenos Aires, Argentina (H.E.G.).
Robson A SantosFrom the Departamento de Química Biológica, IQUIFIB-CONICET, Universidad de Buenos Aires, Argentina (F.M.C., N.L.C., B.D.C., M.M.G.); Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, MI (O.A.C.); Department of Physiology, Federal University of Minas Gerais, Belo Horizonte, Brazil (R.A.S.); and Departamento de Física, Universidad de Buenos Aires and IFIBA-CONICET, Buenos Aires, Argentina (H.E.G.).
Hernán E GreccoFrom the Departamento de Química Biológica, IQUIFIB-CONICET, Universidad de Buenos Aires, Argentina (F.M.C., N.L.C., B.D.C., M.M.G.); Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, MI (O.A.C.); Department of Physiology, Federal University of Minas Gerais, Belo Horizonte, Brazil (R.A.S.); and Departamento de Física, Universidad de Buenos Aires and IFIBA-CONICET, Buenos Aires, Argentina (H.E.G.).
Mariela M GironacciFrom the Departamento de Química Biológica, IQUIFIB-CONICET, Universidad de Buenos Aires, Argentina (F.M.C., N.L.C., B.D.C., M.M.G.); Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, MI (O.A.C.); Department of Physiology, Federal University of Minas Gerais, Belo Horizonte, Brazil (R.A.S.); and Departamento de Física, Universidad de Buenos Aires and IFIBA-CONICET, Buenos Aires, Argentina (H.E.G.). mariela@qb.ffyb.uba.ar marielagironacci@gmail.com.
Henry Ford Hospital · US

Funding

VASOACTIVE HORMONES IN THE REGULATION OF BLOOD PRESSUREP01HL028982 · NHLBI · HENRY FORD HOSPITAL · PI GARVIN, JEFFREY L. · 1985 to 2017
$39.8M
NHLBI NIH HHS P01 HL028982
6 · The paper itself

Abstract

The MAS1 receptor (R) exerts protective effects in the brain, heart, vessels, and kidney. R trafficking plays a critical function in signal termination and propagation and in R resensitization. We examined MAS1R internalization and trafficking on agonist stimulation and the role of β-arrestin2 in the activation of ERK1/2 (extracellular signal-regulated kinase 1/2) and Akt after MAS1R stimulation. Human embryonic kidney 293T cells were transfected with the coding sequence for MAS1R-YFP (MAS1R fused to yellow fluorescent protein). MAS1R internalization was evaluated by measuring the MAS1R present in the plasma membrane after agonist stimulation using a ligand-binding assay. MAS1R trafficking was evaluated by its colocalization with trafficking markers. MAS1R internalization was blocked in the presence of shRNAcaveolin-1 and with dominant negatives for Eps15 (a protein involved in endocytosed Rs by clathrin-coated pits) and for dynamin. After stimulation, MAS1R colocalized with Rab11-a slow recycling vesicle marker-and not with Rab4-a fast recycling vesicle marker-or LysoTracker-a lysosome marker. Cells transfected with MAS1R showed an increase in Akt and ERK1/2 activation on angiotensin-(1-7) stimulation, which was blocked when the clathrin-coated pits pathway was blocked. Suppression of β-arrestin2 by shRNA reduced the angiotensin-(1-7)-induced ERK1/2 activation, whereas Akt activation was not modified. We conclude that on agonist stimulation, MAS1R is internalized through clathrin-coated pits and caveolae in a dynamin-dependent manner and is then slowly recycled back to the plasma membrane. MAS1R induced Akt and ERK1/2 activation from early endosomes, and the activation of ERK1/2 was mediated by β-arrestin2. Thus, MAS1R activity and density may be tightly controlled by the cell.

Indexed as

Angiotensin Ibeta-Arrestin 2EndocytosisEndosomesExtracellular Signal-Regulated MAP KinasesHEK293 CellsHumansPeptide FragmentsProtein TransportProto-Oncogene MasProto-Oncogene ProteinsReceptors, G-Protein-CoupledSignal TransductionAngiotensin Iangiotensin I (1-7)beta-Arrestin 2Extracellular Signal-Regulated MAP KinasesMAS1 protein, humanPeptide FragmentsProto-Oncogene MasProto-Oncogene ProteinsReceptors, G-Protein-Coupledangiotensin-(1–7)arrestinendocytosisendosomesMAS1 receptortrafficking

Identifiers

PMID28874464
PMCPMC5638701
OpenAlexW2751096004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.